HIL-214

BIOLOGICAL4 trials

Sponsors

HilleVax

Conditions

Gastroenteritis

Phase 1

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

CompletedNCT06007781

HilleVaxGastroenteritis

Start: 2023-08-18End: 2024-05-27Updated: 2025-03-14

Phase 2

Efficacy and Safety of Two Doses of HIL-214 in Children

TerminatedNCT05281094

HilleVaxGastroenteritis

Start: 2022-04-28End: 2024-09-30Updated: 2025-07-10

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

CompletedNCT05836012

HilleVaxGastroenteritis

Start: 2023-06-10End: 2024-07-08Updated: 2025-03-12

Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

CompletedNCT05972733

HilleVaxGastroenteritis

Start: 2023-08-01End: 2023-11-10Updated: 2025-08-19